GeorgeRAronoffMD
Nephrology • Denver, COChronic Renal Failure & Dialysis, Hypertension
Vice President, Clinical Affairs, DaVita Kidney Care Chief Medical Officer, Dosis, Inc. Adjunct Professor of Medicine and Pharmacology, University Louisville School of Medicine
Dr. Aronoff is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
World Headquarters
2000 16th Street
Denver, CO 80202
Summary
- Dr. George Aronoff is a nephrologist in Naples, FL. and Denver, CO. He received his medical degree from Indiana University School of Medicine and has been in practice 42 years. He specializes in chronic renal failure & dialysis and hypertension. He is Vice President for Clinical Affairs, DaVita Kidney Care.
Education & Training
Indiana University School of MedicineFellowship, Nephrology, 1979 - 1980- Indiana University School of MedicineResidency, Internal Medicine, 1978 - 1979
- Indiana University School of MedicineFellowship, Nephrology, 1977 - 1978
- Indiana University School of MedicineResidency, Internal Medicine, 1975 - 1977
- Indiana University School of MedicineClass of 1975
Certifications & Licensure
IN State Medical License 1975 - 2025
KY State Medical License 1987 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Nephrology
- American Society of HypertensionCertified Hypertension Specialist
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Top MD Consumers Checkbook
- Whos Who in Medicine and Healthcare Marquis Whos Who
Publications & Presentations
PubMed
- Hexasodium fytate for the treatment of calciphylaxis: a randomised, double-blind, phase 3, placebo-controlled trial with an open-label extension.Smeeta Sinha, Sagar U Nigwekar, Vincent Brandenburg, Lisa J Gould, Thomas E Serena
Eclinicalmedicine. 2024-09-01 - 15 citationsThe CALCIPHYX study: a randomized, double-blind, placebo-controlled, Phase 3 clinical trial of SNF472 for the treatment of calciphylaxisSmeeta Sinha, Lisa J. Gould, Sagar U. Nigwekar, Thomas E Serena, Vincent Brandenburg
Clinical Kidney Journal. 2021-07-06 - 26 citationsIron Administration, Infection, and Anemia Management in CKD: Untangling the Effects of Intravenous Iron Therapy on Immunity and Infection RiskTomas Ganz, George R. Aronoff, Carlo A. J. M. Gaillard, Lawrence T. Goodnough, Iain C. Macdougall
Kidney Medicine. 2020-05-01
Press Mentions
As Financial Incentives Prove Ineffective, Kidney Community Takes Steps to Improve QualityAugust 18th, 2021- Dr. George Aronoff, Chief Medical Officer at Dosis, Inc – Interview SeriesMarch 17th, 2021
- The Promise of Artificial Intelligence in Precision Medication DosingJanuary 22nd, 2021
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
